Some considerations on the design of population pharmacokinetic studiesDUFFULL, Stephen; WATERHOUSE, Tim; ECCLESTON, John et al.Journal of pharmacokinetics and pharmacodynamics (Print). 2005, Vol 32, Num 3-4, pp 441-457, issn 1567-567X, 17 p.Article

The process of knowledge discovery from large pharmacokinetic data setsETTE, Ene I; WILLIAMS, Paul; HE SUN et al.Journal of clinical pharmacology. 2001, Vol 41, Num 1, pp 25-34, issn 0091-2700Article

The odds that clinically unrecognized poor or partial adherence confuses population pharmacokinetic/pharmacodynamic analysesVRIJENS, Bernard; GROSS, Robert; URQUHART, John et al.Basic & clinical pharmacology & toxicology (Print). 2005, Vol 96, Num 3, pp 225-227, issn 1742-7835, 3 p.Article

Population pharmacokinetics of troxacitabine, a novel dioxolane nucleoside analogueLEE, Carlton K. K; ROWINSKY, Eric K; JING LI et al.Clinical cancer research. 2006, Vol 12, Num 7, pp 2158-2165, issn 1078-0432, 8 p., 1Article

Dealing with time-dependent pharmacokinetics during the early clinical development of a new leukotriene B₄ synthesis inhibitorTROCONIZ, Inaki F; ZSOLT, Ilonka; GARRIDO, Maria J et al.Pharmaceutical research. 2006, Vol 23, Num 7, pp 1533-1542, issn 0724-8741, 10 p.Article

Population pharmacokinetics of mycophenolic acid during the first week after renal transplantationSTAATZ, Christine E; DUFFULL, Stephen B; KIBERD, Bryce et al.European journal of clinical pharmacology. 2005, Vol 61, Num 7, pp 507-516, issn 0031-6970, 10 p.Article

Models for time-varying covariates in population pharmacokinetic-pharmacodynamic analysisWÄHLBY, Ulrika; THOMSON, Alison H; MILLIGAN, Peter A et al.British journal of clinical pharmacology. 2004, Vol 58, Num 4, pp 367-377, issn 0306-5251, 11 p.Article

Probability of target attainment for ceftobiprole as derived from a population pharmacokinetic analysis of 150 subjectsLODISE, Thomas P; PYPSTRA, Rienk; KAHN, James B et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 7, pp 2378-2387, issn 0066-4804, 10 p.Article

Phenylacetate pharmacokinetics based on iterative two-stage population analysisBURSTEIN, Aaron H; REED, Eddie; TOMPKINS, Anne C et al.Pharmacotherapy. 2001, Vol 21, Num 3, pp 281-286, issn 0277-0008Conference Paper

Applications of population pharmacokinetics in current drug labellingDUAN, J. Z.Journal of clinical pharmacy and therapeutics (Print). 2007, Vol 32, Num 1, pp 57-79, issn 0269-4727, 23 p.Article

Population pharmacokinetics of darbepoetin alfa in healthy subjectsAGORAM, Balaji; SUTJANDRA, Liviawati; SULLIVAN, John T et al.British journal of clinical pharmacology. 2007, Vol 63, Num 1, pp 41-52, issn 0306-5251, 12 p.Article

Population pharmacokinetic investigation of disopyramide by mixed effect modelling using routine clinical pharmacokinetic data in Japanese patientsYUKAWA, E; ORIO, K; YUKAWA, M et al.Journal of clinical pharmacy and therapeutics (Print). 2005, Vol 30, Num 4, pp 401-405, issn 0269-4727, 5 p.Article

Robust population pharmacokinetic experiment designDODDS, Michael G; HOOKER, Andrew C; VICINI, Paolo et al.Journal of pharmacokinetics and pharmacodynamics (Print). 2005, Vol 32, Num 1, pp 33-64, issn 1567-567X, 32 p.Article

Bayesian analysis of population PK/PD models: General concepts and softwareLUNN, David J; BEST, Nicky; THOMAS, Andrew et al.Journal of pharmacokinetics and pharmacodynamics (Print). 2002, Vol 29, Num 3, pp 271-307, issn 1567-567X, 37 p.Article

Population pharmacokinetics of flucytosine : Comparison and validation of three models using STS, NPEM, and NONMEMVERMES, Andras; MATHOT, Ron A. A; VAN DER SIJS, I. Heleen et al.Therapeutic drug monitoring. 2000, Vol 22, Num 6, pp 676-687, issn 0163-4356Article

Expanding clinical applications of population pharmacodynamic modellingMINTO, C; SCHNIDER, T.British journal of clinical pharmacology. 1998, Vol 46, Num 4, pp 321-333, issn 0306-5251Conference Paper

Paracetamol plasma and cerebrospinal fluid pharmacokinetics in childrenANDERSON, B. J; HOLFORD, N. H. G; WOOLLARD, G. A et al.British journal of clinical pharmacology. 1998, Vol 46, Num 3, pp 237-243, issn 0306-5251Conference Paper

Population pharmacokinetics of tafenoquine during malaria prophylaxis in healthy subjectsCHARLES, Bruce G; MILLER, Ann K; NASVELD, Peter E et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 8, pp 2709-2715, issn 0066-4804, 7 p.Article

Cluster analysis : An alternative method for covariate selection in population pharmacokinetic modelingSEMMAR, Nabil; BRUGUEROLLE, Bernard; BOULLU-CIOCCA, Sandrine et al.Journal of pharmacokinetics and pharmacodynamics (Print). 2005, Vol 32, Num 3-4, pp 333-358, issn 1567-567X, 26 p.Article

Population pharmacokinetic modelling of BIBN 4096 BS, the first compound of the new class of calcitonin gene-related peptide receptor antagonistsTROCONIZ, Inaki F; WOLTERS, Jan-Markus; SCHAEFER, Hans Guenter et al.European journal of pharmaceutical sciences. 2004, Vol 22, Num 4, pp 287-295, issn 0928-0987, 9 p.Article

Population pharmacokinetics of gentamicin in South African newbornsBOTHA, J. H; DU PREEZ, M. J; ADHIKARI, M et al.European journal of clinical pharmacology. 2003, Vol 59, Num 10, pp 755-759, issn 0031-6970, 5 p.Article

Assessment of type I error rates for the statistical sub-model in NONMEMWÄHLBY, Ulrika; BOUW, M. Rene; JONSSON, E. Niclas et al.Journal of pharmacokinetics and pharmacodynamics (Print). 2002, Vol 29, Num 3, pp 251-269, issn 1567-567X, 19 p.Article

Population pharmacokinetic study of methotrexate in patients with lymphoid malignancyFALTAOS, Demiana William; HULOT, Jean Sebastian; URIEN, Saïk et al.Cancer chemotherapy and pharmacology. 2006, Vol 58, Num 5, pp 626-633, issn 0344-5704, 8 p.Article

Population pharmacokinetic analysis of vancomycin in patients with hematological malignanciesSANTOS BUELGA, Dolores; FERNANDEZ DE GATTA, Maria Del; HERRERA, Emma V et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 12, pp 4934-4941, issn 0066-4804, 8 p.Article

Population plasma pharmacokinetics of ¹¹C-flumazenil at tracer concentrationsVAN RIJ, Catharina M; HUITEMA, Alwin D. R; SWART, Eleonora L et al.British journal of clinical pharmacology. 2005, Vol 60, Num 5, pp 477-485, issn 0306-5251, 9 p.Article